JP2023111915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023111915A5 JP2023111915A5 JP2023084035A JP2023084035A JP2023111915A5 JP 2023111915 A5 JP2023111915 A5 JP 2023111915A5 JP 2023084035 A JP2023084035 A JP 2023084035A JP 2023084035 A JP2023084035 A JP 2023084035A JP 2023111915 A5 JP2023111915 A5 JP 2023111915A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- amino acid
- acid sequence
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical group 0.000 claims 44
- 239000012634 fragment Substances 0.000 claims 25
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 20
- 108020004707 nucleic acids Proteins 0.000 claims 18
- 102000039446 nucleic acids Human genes 0.000 claims 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims 15
- 235000004279 alanine Nutrition 0.000 claims 11
- 125000000539 amino acid group Chemical group 0.000 claims 11
- 235000018102 proteins Nutrition 0.000 claims 11
- 102000004169 proteins and genes Human genes 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 8
- 239000002773 nucleotide Substances 0.000 claims 7
- 125000003729 nucleotide group Chemical group 0.000 claims 7
- 239000013598 vector Substances 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 230000008488 polyadenylation Effects 0.000 claims 3
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims 1
- 108010006025 bovine growth hormone Proteins 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025018136A JP2025065334A (ja) | 2017-12-13 | 2025-02-06 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762598329P | 2017-12-13 | 2017-12-13 | |
| US62/598,329 | 2017-12-13 | ||
| US201762598612P | 2017-12-14 | 2017-12-14 | |
| US62/598,612 | 2017-12-14 | ||
| JP2020532714A JP7314139B2 (ja) | 2017-12-13 | 2018-12-13 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
| PCT/US2018/065534 WO2019118771A1 (en) | 2017-12-13 | 2018-12-13 | Cancer vaccines targeting lemd1 and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532714A Division JP7314139B2 (ja) | 2017-12-13 | 2018-12-13 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018136A Division JP2025065334A (ja) | 2017-12-13 | 2025-02-06 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023111915A JP2023111915A (ja) | 2023-08-10 |
| JP2023111915A5 true JP2023111915A5 (https=) | 2023-12-08 |
| JP7633306B2 JP7633306B2 (ja) | 2025-02-19 |
Family
ID=66734873
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532714A Active JP7314139B2 (ja) | 2017-12-13 | 2018-12-13 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
| JP2023084035A Active JP7633306B2 (ja) | 2017-12-13 | 2023-05-22 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
| JP2025018136A Withdrawn JP2025065334A (ja) | 2017-12-13 | 2025-02-06 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532714A Active JP7314139B2 (ja) | 2017-12-13 | 2018-12-13 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018136A Withdrawn JP2025065334A (ja) | 2017-12-13 | 2025-02-06 | Ｌｅｍｄ１を標的とするがんワクチンおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11338028B2 (https=) |
| EP (1) | EP3724217A4 (https=) |
| JP (3) | JP7314139B2 (https=) |
| KR (2) | KR20240096711A (https=) |
| CN (1) | CN111479822A (https=) |
| AU (2) | AU2018384824B2 (https=) |
| BR (1) | BR112020011620A2 (https=) |
| CA (1) | CA3084137A1 (https=) |
| MX (2) | MX2020006305A (https=) |
| RU (1) | RU2760984C1 (https=) |
| WO (1) | WO2019118771A1 (https=) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60238143D1 (de) * | 2001-09-18 | 2010-12-09 | Genentech Inc | Zusammensetzungen und verfahren für die diagnose von tumoren |
| WO2004021010A2 (en) * | 2002-08-30 | 2004-03-11 | Oncotherapy Science, Inc. | Method of diagnosing colon and gastric cancers |
| US20090275021A1 (en) * | 2005-11-27 | 2009-11-05 | Osnat Sella-Tavor | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| KR101543622B1 (ko) * | 2006-10-17 | 2015-08-11 | 온코세라피 사이언스 가부시키가이샤 | Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신 |
| KR101174452B1 (ko) * | 2009-05-11 | 2012-08-16 | 한국생명공학연구원 | 대장암 및 전이에 대한 바이오마커, 이를 이용한 대장암 진단 및 치료제 스크리닝 |
| PL391627A1 (pl) * | 2010-06-25 | 2012-01-02 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
| EP2751570A4 (en) * | 2011-08-31 | 2015-08-12 | Oncocyte Corp | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER |
| US20140315743A1 (en) * | 2011-10-03 | 2014-10-23 | Karen Chapman | Methods and Compositions for the Treatment and Diagnosis of Ovarian Cancer |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| CN104812401B (zh) * | 2012-12-13 | 2017-10-13 | 宾夕法尼亚大学理事会 | Wt1疫苗 |
| US12018331B2 (en) * | 2016-05-23 | 2024-06-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods of diagnosing cancer using cancer testis antigens |
-
2018
- 2018-12-13 AU AU2018384824A patent/AU2018384824B2/en active Active
- 2018-12-13 CN CN201880080531.2A patent/CN111479822A/zh active Pending
- 2018-12-13 EP EP18887820.1A patent/EP3724217A4/en not_active Withdrawn
- 2018-12-13 WO PCT/US2018/065534 patent/WO2019118771A1/en not_active Ceased
- 2018-12-13 KR KR1020247018738A patent/KR20240096711A/ko active Pending
- 2018-12-13 US US16/219,446 patent/US11338028B2/en active Active
- 2018-12-13 JP JP2020532714A patent/JP7314139B2/ja active Active
- 2018-12-13 MX MX2020006305A patent/MX2020006305A/es unknown
- 2018-12-13 KR KR1020207019769A patent/KR102673699B1/ko active Active
- 2018-12-13 RU RU2020122873A patent/RU2760984C1/ru active
- 2018-12-13 CA CA3084137A patent/CA3084137A1/en active Pending
- 2018-12-13 BR BR112020011620-3A patent/BR112020011620A2/pt active Search and Examination
-
2020
- 2020-07-13 MX MX2024005404A patent/MX2024005404A/es unknown
-
2022
- 2022-04-25 US US17/728,671 patent/US20220265800A1/en not_active Abandoned
- 2022-11-03 AU AU2022263546A patent/AU2022263546A1/en not_active Abandoned
-
2023
- 2023-05-22 JP JP2023084035A patent/JP7633306B2/ja active Active
-
2025
- 2025-02-06 JP JP2025018136A patent/JP2025065334A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023544683A5 (https=) | ||
| EP3319633B1 (en) | Vaccine against rsv | |
| JP2024026738A (ja) | 免疫調節融合タンパク質 | |
| JP2023512519A5 (https=) | ||
| JP2023519640A5 (https=) | ||
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| JP2025184979A5 (https=) | ||
| JP2021520203A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| FI3906066T3 (fi) | Geeniterapiakonstrukteja wilsonin taudin hoitamiseksi | |
| CN101903400B (zh) | 使用固相和液相组合技术的促胰岛素肽合成 | |
| JP2008507292A (ja) | リンカー | |
| JP2020520662A5 (https=) | ||
| JP2020510430A5 (https=) | ||
| JP2008507298A5 (https=) | ||
| KR20090111320A (ko) | 항종양 활성을 갖는 신규한 폴리펩티드 | |
| JP2022505877A5 (https=) | ||
| JP2022541520A5 (https=) | ||
| JP2019534884A5 (https=) | ||
| JP2024522385A5 (https=) | ||
| JP2023542453A5 (https=) | ||
| JP2022529500A5 (https=) | ||
| JP2024503091A5 (https=) | ||
| JP2006511212A5 (https=) | ||
| JP2023540599A5 (https=) |